youtube_live
Q3 2026 earnings • released • EPS miss -49.86% • Revenue beat +12.22%
See resultschevron_right
NTRA:NASDAQ
Natera Inc
$314.26
arrow_downward
-13.61%(-49.51) 1D
Nov 6, 12:59:38 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
$319.99
High
$327.53
Low
$304.00
Mkt. cap
45.20B
Avg. vol.
1.84M
Volume
3.15M
52-wk high
$437.41
52-wk low
$181.00
EPS
-$1.37
Beta
1.55
Shares outstanding
144.14M
No. of employees
6K
Open
$319.99
High
$327.53
Low
$304.00
Mkt. cap
45.20B
Avg. vol.
1.84M
Volume
3.15M
52-wk high
$437.41
52-wk low
$181.00
EPS
-$1.37
Beta
1.55
Shares outstanding
144.14M
No. of employees
6K
News stories
From web sources and news partners
Yahoo Finance
·
52 minutes ago
Natera Stocks Slide 15.07% After Wider Loss and Sudden CEO Change
Benzinga
·
1 hour ago
Natera Stock Plummets After Mixed Q3 Financials
Benzinga
·
2 hours ago
If You Invested $100 In Natera Stock 10 Years Ago, You Would Have This Much Today
Investor's Business Daily
·
2 hours ago
Blood-Testing Gore Continues As Natera, Guardant Report
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorHealth Care
IndustryBiotechnology
Websitenatera.com